My Bibliography

select

Schmitt TM, Furiya K, Black C, Vazquez A, Sharma J, Hailemariam M, Paushter DH, Trieu L, Lam J, Lee B, Rakhra K, Whalen KA, Mehta NK, Sauer K, Baeuerle PA, Michaelson JS, Greenberg PD, Chapuis AG. Dysregulated expression of the tumor suppressor p14ARF in cancer provides an effective target for TCR-T cell therapeutics. J Immunother Cancer. 2026 Feb 4;14(2). doi: 10.1136/jitc-2025-013520. PubMed PMID: 41638872; PubMed Central PMCID: PMC12878313.

select

Cheng H, Su Y, Pan X, Xu Y, Xie E, Du J, Chen DG, Dai X, Gottardo R, Greenberg PD, Li G. The ubiquitin ligase KLHL6 drives resistance to CD8(+) T cell dysfunction. Nature. 2026 Mar;651(8105):451-461. doi: 10.1038/s41586-025-09926-8. Epub 2026 Jan 14. PubMed PMID: 41535474; PubMed Central PMCID: PMC12979199.

select

Zhang S, Tang TH, Kinsella S, Mazziotta F, Schweizer MT, McAfee MS, Munkhbat A, Su Y, Voillet V, Martin LE, Smith CW, Asano Y, Hailemariam M, Bakhtiari J, Lee B, Yeung C, Chen H, Rizzi AM, Chen DG, Furiya K, Horst N, Zhang T, Le P, McKenna K, Oda SK, Rongvaux A, Greenberg PD, Schmitt TM, Chapuis AG. A CD8αβ co-receptor modified to contain an intracellular CD28 signaling tail enhances TCR-engineered T cell function independent of solid-tumor-associated co-stimulatory ligands. Nat Commun. 2026 Jan 3;17(1):753. doi: 10.1038/s41467-025-67446-5. PubMed PMID: 41484084; PubMed Central PMCID: PMC12820041.

select

Masopust D, Awasthi A, Bosselut R, Brooks DG, Buggert M, Chamoto K, Cui W, Dong C, Farber DL, Gebhardt T, Gerlach C, Goldrath A, Greenberg PD, Hale JS, Hayday A, Homann D, Iannacone M, Jameson SC, Jenkins MK, Joshi NS, Kaech SM, Kallies A, Kamphorst AO, Kaplan MH, Klenerman P, Künzli M, Lanzavecchia A, Lauer GM, Lugli E, Luster AD, Mackay LK, McElrath MJ, Mueller SN, Ndhlovu Z, Ndung'u T, Ohashi PS, Oxenius A, Pantaleo G, Pepper M, Picker LJ, Quarnstrom CF, Reyes-Terán G, Roederer M, Rosato PC, de Oca GS, Sallusto F, Schumacher TN, Schwartz DM, Shin EC, Soerens AG, Thommen DS, Vezys V, Viola JPB, Walker BD, Watts TH, Weaver CT, Wherry EJ, Xue HH, Youngblood B, Ahmed R. Guidelines for T cell nomenclature. Nat Rev Immunol. 2026 Apr;26(4):298-313. doi: 10.1038/s41577-025-01238-2. Epub 2025 Nov 18. Review. PubMed PMID: 41254224.

select

Su Y, Thelen A, Wirth LV, Jenkins CM, Mak SR, Chen DG, Gottardo R, Greenberg PD. A TGF-βR/IL-2R immunomodulatory fusion protein transforms immunosuppression into T cell activation to enhance adoptive T cell therapy. Proc Natl Acad Sci U S A. 2025 Sep 30;122(39):e2516951122. doi: 10.1073/pnas.2516951122. Epub 2025 Sep 23. PubMed PMID: 40986340; PubMed Central PMCID: PMC12501114.

select

Alencar GF, Mohamed AO, Burnett MG, Jean SS, Nelson AR, Su Y, Voillet V, Bates BM, Rodgers Suarez M, Ruskin SL, Trieu L, Lam JL, Bekiranov S, Gottardo R, Greenberg PD, Anderson KG. Triple checkpoint blockade of PD-1, Tim-3, and Lag-3 enhances adoptive T cell immunotherapy in a mouse model of ovarian cancer. Proc Natl Acad Sci U S A. 2025 Sep 30;122(39):e2419888122. doi: 10.1073/pnas.2419888122. Epub 2025 Sep 22. PubMed PMID: 40982684; PubMed Central PMCID: PMC12501118.

select

Shasha C, Glass DR, Moelhman E, Islas L, Tian Y, Chour T, Xu G, Szeto GL, Peng T, Song X, Wurscher M, Cowan AJ, Bumol TF, Torgerson TR, Greenberg PD, Green DJ, Newell EW. Hallmarks of T-cell exhaustion and antigen experience are absent in multiple myeloma from diagnosis to maintenance therapy. Blood. 2025 Jun 26;145(26):3113-3123. doi: 10.1182/blood.2024025655. PubMed PMID: 40163891; PubMed Central PMCID: PMC12782984.

select

Mazziotta F, Martin LE, Egan DN, Bar M, Kinsella S, Paulson KG, Voillet V, Lahman MC, Hunter D, Schmitt TM, Duerkopp N, Yeung CCS, Tang TH, Gottardo R, Asano Y, Wilcox EC, Lee B, Zhang T, Lopedote P, Penter L, Wu CJ, Milano F, Greenberg PD, Chapuis AG. A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence. Nat Commun. 2025 Jun 5;16(1):5214. doi: 10.1038/s41467-025-60394-0. PubMed PMID: 40473616; PubMed Central PMCID: PMC12141728.

select

Cabanski CR, Yang E, Stewart MD, Allen JD, Connolly JE, Dugan U, Greenberg PD, Mackall CL, June CH, Marson A, Maus MV, Ribas A. Intentional heterogeneity in autologous cell-based gene therapies: strategic considerations for first-in-human trials. J Immunother Cancer. 2025 Jun 5;13(6). doi: 10.1136/jitc-2024-011301. Review. PubMed PMID: 40480658; PubMed Central PMCID: PMC12142127.

select

Ely ZA, Kulstad ZJ, Gunaydin G, Addepalli S, Verzani EK, Casarrubios M, Clauser KR, Wang X, Lippincott IE, Louvet C, Schmitt T, Kapner KS, Agus MP, Hennessey CJ, Cleary JM, Hadrup SR, Klaeger S, Su J, Jaeger AM, Wolpin BM, Raghavan S, Smith EL, Greenberg PD, Aguirre AJ, Abelin JG, Carr SA, Jacks T, Freed-Pastor WA. Pancreatic cancer-restricted cryptic antigens are targets for T cell recognition. Science. 2025 May 8;388(6747):eadk3487. doi: 10.1126/science.adk3487. Epub 2025 May 8. PubMed PMID: 40339010; PubMed Central PMCID: PMC12163983.

select

Xie J, Chen DG, Chour W, Ng RH, Zhang R, Yuan D, Choi J, McKasson M, Troisch P, Smith B, Jones L, Webster A, Rasheed Y, Li S, Edmark R, Hong S, Murray KM, Logue JK, Franko NM, Lausted CG, Piening B, Algren H, Wallick J, Magis AT, Watanabe K, Mease P, Greenberg PD, Chu H, Goldman JD, Su Y, Heath JR. APMAT analysis reveals the association between CD8 T cell receptors, cognate antigen, and T cell phenotype and persistence. Nat Commun. 2025 Feb 6;16(1):1402. doi: 10.1038/s41467-025-56659-3. PubMed PMID: 39915487; PubMed Central PMCID: PMC11802929.

select

Xie J, Chen DG, Chour W, Ng RH, Zhang R, Yuan D, Choi J, McKasson M, Troisch P, Smith B, Jones L, Webster A, Rasheed Y, Li S, Edmark R, Hong S, Murray KM, Logue JK, Franko NM, Lausted CG, Piening B, Algren H, Wallick J, Magis AT, Watanabe K, Mease P, Greenberg PD, Chu H, Goldman JD, Su Y, Heath JR. APMAT analysis reveals the association between CD8 T cell receptors, cognate antigen, and T cell phenotype and persistence. bioRxiv. 2025 Jan 9;. doi: 10.1101/2025.01.08.631993. PubMed PMID: 39829843; PubMed Central PMCID: PMC11741388.

select

Mazziotta F, Martin LE, Eagan DN, Bar M, Kinsella S, Paulson KG, Voillet V, Lahman MC, Hunter D, Schmitt TM, Duerkopp N, Yeung C, Tang TH, Gottardo R, Asano Y, Wilcox EC, Lee B, Zhang T, Lopedote P, Penter L, Wu CJ, Milano F, Greenberg PD, Chapuis AG. Acute Myeloid Leukemia Skews Therapeutic WT1-specific CD8 TCR-T Cells Towards an NK-like Phenotype that Compromises Function and Persistence. medRxiv. 2024 Dec 16;. doi: 10.1101/2024.12.13.24318504. PubMed PMID: 39763516; PubMed Central PMCID: PMC11702715.

select

Qiu Y, Su Y, Xie E, Cheng H, Du J, Xu Y, Pan X, Wang Z, Chen DG, Zhu H, Greenberg PD, Li G. Mannose metabolism reshapes T cell differentiation to enhance anti-tumor immunity. Cancer Cell. 2025 Jan 13;43(1):103-121.e8. doi: 10.1016/j.ccell.2024.11.003. Epub 2024 Dec 5. PubMed PMID: 39642888; PubMed Central PMCID: PMC11756673.

select

Gupta S, Martinov T, Thelen A, Sunahara M, Mureli S, Vazquez A, Gerdts J, Dandekar R, Cortese I, Fouassier C, Schanzer E, Urnov FD, Marson A, Shy BR, Greenberg PD, Wilson MR. Antigen-Specific T Cell Receptor Discovery for Treating Progressive Multifocal Leukoencephalopathy. bioRxiv. 2024 Nov 4;. doi: 10.1101/2024.11.04.621904. PubMed PMID: 39574748; PubMed Central PMCID: PMC11580961.

select

Lee JW, Chen EY, Hu T, Perret R, Chaffee ME, Martinov T, Mureli S, McCurdy CL, Jones LA, Gafken PR, Chanana P, Su Y, Chapuis AG, Bradley P, Schmitt TM, Greenberg PD. Overcoming immune evasion from post-translational modification of a mutant KRAS epitope to achieve TCR-T cell-mediated antitumor activity. bioRxiv. 2024 Oct 14;. doi: 10.1101/2024.09.18.612965. PubMed PMID: 39345486; PubMed Central PMCID: PMC11429761.

select

Krakow EF, Brault M, Summers C, Cunningham TM, Biernacki MA, Black RG, Woodward KB, Vartanian N, Kanaan SB, Yeh AC, Dossa RG, Bar M, Cassaday RD, Dahlberg A, Till BG, Denker AE, Yeung CCS, Gooley TA, Maloney DG, Riddell SR, Greenberg PD, Chapuis AG, Newell EW, Furlan SN, Bleakley M. HA-1-targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation. Blood. 2024 Sep 5;144(10):1069-1082. doi: 10.1182/blood.2024024105. PubMed PMID: 38683966; PubMed Central PMCID: PMC11406181.

select

Asano Y, Veatch J, McAfee M, Bakhtiari J, Lee B, Martin L, Zhang S, Mazziotta F, Paulson KG, Schmitt TM, Munkbhat A, Young C, Seaton B, Hunter D, Horst N, Lindberg M, Miller N, Stone M, Bielas J, Koelle D, Voillet V, Gottardo R, Gooley T, Oda S, Greenberg PD, Nghiem P, Chapuis AG. Tumor Regression Following Engineered Polyomavirus-Specific T Cell Therapy in Immune Checkpoint Inhibitor-Refractory Merkel Cell Carcinoma. medRxiv. 2024 Jul 5;. doi: 10.1101/2024.07.01.24309780. PubMed PMID: 39006423; PubMed Central PMCID: PMC11245074.

select

Shasha C, Glass DR, Moelhman E, Islas L, Tian Y, Szeto GL, Peng T, Song X, Wurscher M, Bumol TF, Torgerson TR, Greenberg PD, Green DJ, Newell EW. Hallmarks of tumor-experienced T cells are absent in multiple myeloma patients from diagnosis through maintenance therapy. bioRxiv. 2024 Jun 4;. doi: 10.1101/2024.06.03.597178. PubMed PMID: 38895348; PubMed Central PMCID: PMC11185627.

select

Chour W, Choi J, Xie J, Chaffee ME, Schmitt TM, Finton K, DeLucia DC, Xu AM, Su Y, Chen DG, Zhang R, Yuan D, Hong S, Ng AHC, Butler JZ, Edmark RA, Jones LC, Murray KM, Peng S, Li G, Strong RK, Lee JK, Goldman JD, Greenberg PD, Heath JR. Large libraries of single-chain trimer peptide-MHCs enable antigen-specific CD8+ T cell discovery and analysis. Commun Biol. 2023 May 16;6(1):528. doi: 10.1038/s42003-023-04899-8. PubMed PMID: 37193826; PubMed Central PMCID: PMC10186326.

select

Nava Lauson CB, Tiberti S, Corsetto PA, Conte F, Tyagi P, Machwirth M, Ebert S, Loffreda A, Scheller L, Sheta D, Mokhtari Z, Peters T, Raman AT, Greco F, Rizzo AM, Beilhack A, Signore G, Tumino N, Vacca P, McDonnell LA, Raimondi A, Greenberg PD, Huppa JB, Cardaci S, Caruana I, Rodighiero S, Nezi L, Manzo T. Linoleic acid potentiates CD8(+) T cell metabolic fitness and antitumor immunity. Cell Metab. 2023 Apr 4;35(4):633-650.e9. doi: 10.1016/j.cmet.2023.02.013. Epub 2023 Mar 9. PubMed PMID: 36898381.

select

Martinov T, Greenberg PD. Targeting Driver Oncogenes and Other Public Neoantigens Using T Cell Receptor-Based Cellular Therapy. Annu Rev Cancer Biol. 2023;7(1):331-351. doi: 10.1146/annurev-cancerbio-061521-082114. Epub 2023 Jan 25. PubMed PMID: 37655310; PubMed Central PMCID: PMC10470615.

select

Schreiber RD, Greenberg PD. Cancer Immunology Research: A Decade of Illumination and Innovation. Cancer Immunol Res. 2023 Jan 3;11(1):2. doi: 10.1158/2326-6066.CIR-22-0952. PubMed PMID: 36594238.

select

Heath J, Chour W, Choi J, Xie J, Chaffee M, Schmitt T, Finton K, Delucia D, Xu A, Su Y, Chen D, Zhang R, Yuan D, Hong S, Ng A, Butler J, Edmark R, Jones L, Murray K, Peng S, Li G, Strong R, Lee J, Goldman J, Greenberg P. Large libraries of single-chain trimer peptide-MHCs enable rapid antigen-specific CD8+ T cell discovery and analysis. Res Sq. 2022 Nov 18;. doi: 10.21203/rs.3.rs-1090664/v1. PubMed PMID: 36415462; PubMed Central PMCID: PMC9681053.

select

Anderson KC, Cantley LC, Dalla-Favera R, Dang CV, Diaz LA, DuBois RN, Flaherty KT, Greenberg PD, Loda M, Mardis ER, Platz EA, Pollak MN, Schreiber RD, Siu LL, Teicher BA. The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission. Mol Cancer Ther. 2022 Nov 3;21(11):1625-1631. doi: 10.1158/1535-7163.MCT-22-0655. PubMed PMID: 36325690.

select

Anderson KC, Cantley LC, Dalla-Favera R, Dang CV, Diaz LA, DuBois RN, Flaherty KT, Greenberg PD, Loda M, Mardis ER, Platz EA, Pollak MN, Schreiber RD, Siu LL, Teicher BA. The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission. Mol Cancer Res. 2022 Nov 3;20(11):1591-1597. doi: 10.1158/1541-7786.MCR-22-0804. PubMed PMID: 36325685.

select

Anderson KC, Cantley LC, Dalla-Favera R, Dang CV, Diaz LA, DuBois RN, Flaherty KT, Greenberg PD, Loda M, Mardis ER, Platz EA, Pollak MN, Schreiber RD, Siu LL, Teicher BA. The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission. Cancer Discov. 2022 Nov 2;12(11):2475-2481. doi: 10.1158/2159-8290.CD-22-1105. PubMed PMID: 36321306.

select

Anderson KC, Cantley LC, Dalla-Favera R, Dang CV, Diaz LA, DuBois RN, Flaherty KT, Greenberg PD, Loda M, Mardis ER, Platz EA, Pollak MN, Schreiber RD, Siu LL, Teicher BA. The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission. Cancer Epidemiol Biomarkers Prev. 2022 Nov 2;31(11):1995-2001. doi: 10.1158/1055-9965.EPI-22-0852. PubMed PMID: 36321301.

select

Anderson KC, Cantley LC, Dalla-Favera R, Dang CV, Diaz LA, DuBois RN, Flaherty KT, Greenberg PD, Loda M, Mardis ER, Platz EA, Pollak MN, Schreiber RD, Siu LL, Teicher BA. The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission. Cancer Immunol Res. 2022 Nov 2;10(11):1282-1288. doi: 10.1158/2326-6066.CIR-22-0782. PubMed PMID: 36321298.

select

Anderson KC, Cantley LC, Dalla-Favera R, Dang CV, Diaz LA, DuBois RN, Flaherty KT, Greenberg PD, Loda M, Mardis ER, Platz EA, Pollak MN, Schreiber RD, Siu LL, Teicher BA. The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission. Blood Cancer Discov. 2022 Nov 2;3(6):469-475. doi: 10.1158/2643-3230.BCD-22-0165. PubMed PMID: 36321294; PubMed Central PMCID: PMC9627237.

select

Anderson KC, Cantley LC, Dalla-Favera R, Dang CV, Diaz LA, DuBois RN, Flaherty KT, Greenberg PD, Loda M, Mardis ER, Platz EA, Pollak MN, Schreiber RD, Siu LL, Teicher BA. The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission. Cancer Res. 2022 Nov 2;82(21):3861-3867. doi: 10.1158/0008-5472.CAN-22-2453. PubMed PMID: 36321264.

select

Anderson KC, Cantley LC, Dalla-Favera R, Dang CV, Diaz LA, DuBois RN, Flaherty KT, Greenberg PD, Loda M, Mardis ER, Platz EA, Pollak MN, Schreiber RD, Siu LL, Teicher BA. The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission. Clin Cancer Res. 2022 Nov 1;28(21):4593-4599. doi: 10.1158/1078-0432.CCR-22-3167. PubMed PMID: 36317374.

select

Anderson KC, Cantley LC, Dalla-Favera R, Dang CV, Diaz LA, DuBois RN, Flaherty KT, Greenberg PD, Loda M, Mardis ER, Platz EA, Pollak MN, Schreiber RD, Siu LL, Teicher BA. The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission. Cancer Prev Res (Phila). 2022 Nov 1;15(11):705-712. doi: 10.1158/1940-6207.CAPR-22-0369. PubMed PMID: 36317369.

select

Paras G, Morsink LM, Othus M, Milano F, Sandmaier BM, Zarling LC, Palmieri R, Schoch G, Davis C, Bleakley M, Flowers MED, Deeg HJ, Appelbaum FR, Storb R, Walter RB. Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML. Blood. 2022 Mar 17;139(11):1694-1706. doi: 10.1182/blood.2021014804. PubMed PMID: 34995355; PubMed Central PMCID: PMC8931514.

select

Anderson KG, Oda SK, Bates BM, Burnett MG, Rodgers Suarez M, Ruskin SL, Greenberg PD. Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy. J Immunother Cancer. 2022 Mar;10(3). doi: 10.1136/jitc-2021-003959. PubMed PMID: 35264436; PubMed Central PMCID: PMC8915280.

select

Lahman MC, Schmitt TM, Paulson KG, Vigneron N, Buenrostro D, Wagener FD, Voillet V, Martin L, Gottardo R, Bielas J, McElrath JM, Stirewalt DL, Pogosova-Agadjanyan EL, Yeung CC, Pierce RH, Egan DN, Bar M, Hendrie PC, Kinsella S, Vakil A, Butler J, Chaffee M, Linton J, McAfee MS, Hunter DS, Bleakley M, Rongvaux A, Van den Eynde BJ, Chapuis AG, Greenberg PD. Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency. Sci Transl Med. 2022 Feb 9;14(631):eabg8070. doi: 10.1126/scitranslmed.abg8070. Epub 2022 Feb 9. PubMed PMID: 35138909; PubMed Central PMCID: PMC8985599.

select

Stromnes IM, Hulbert A, Rollins MR, Basom RS, Delrow J, Bonson P, Burrack AL, Hingorani SR, Greenberg PD. Insufficiency of compound immune checkpoint blockade to overcome engineered T cell exhaustion in pancreatic cancer. J Immunother Cancer. 2022 Feb;10(2). doi: 10.1136/jitc-2021-003525. PubMed PMID: 35210305; PubMed Central PMCID: PMC8883283.

select

Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, Li S, Hong S, Zhang R, Xie J, Kornilov SA, Scherler K, Pavlovitch-Bedzyk AJ, Dong S, Lausted C, Lee I, Fallen S, Dai CL, Baloni P, Smith B, Duvvuri VR, Anderson KG, Li J, Yang F, Duncombe CJ, McCulloch DJ, Rostomily C, Troisch P, Zhou J, Mackay S, DeGottardi Q, May DH, Taniguchi R, Gittelman RM, Klinger M, Snyder TM, Roper R, Wojciechowska G, Murray K, Edmark R, Evans S, Jones L, Zhou Y, Rowen L, Liu R, Chour W, Algren HA, Berrington WR, Wallick JA, Cochran RA, Micikas ME, ISB-Swedish COVID-19 Biobanking Unit, Wrin T, Petropoulos CJ, Cole HR, Fischer TD, Wei W, Hoon DSB, Price ND, Subramanian N, Hill JA, Hadlock J, Magis AT, Ribas A, Lanier LL, Boyd SD, Bluestone JA, Chu H, Hood L, Gottardo R, Greenberg PD, Davis MM, Goldman JD, Heath JR. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022 Mar 3;185(5):881-895.e20. doi: 10.1016/j.cell.2022.01.014. Epub 2022 Jan 25. PubMed PMID: 35216672; PubMed Central PMCID: PMC8786632.

select

Schreiber RD, Greenberg PD. A New Year, A New Initiative. Cancer Immunol Res. 2022 Jan;10(1):2. doi: 10.1158/2326-6066.CIR-21-0999. PubMed PMID: 34983826.

select

Lee JW, Su Y, Baloni P, Chen D, Pavlovitch-Bedzyk AJ, Yuan D, Duvvuri VR, Ng RH, Choi J, Xie J, Zhang R, Murray K, Kornilov S, Smith B, Magis AT, Hoon DSB, Hadlock JJ, Goldman JD, Price ND, Gottardo R, Davis MM, Hood L, Greenberg PD, Heath JR. Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19. Nat Biotechnol. 2022 Jan;40(1):110-120. doi: 10.1038/s41587-021-01020-4. Epub 2021 Sep 6. PubMed PMID: 34489601; PubMed Central PMCID: PMC9206886.

select

Oda SK, Anderson KG, Ravikumar P, Bonson P, Garcia NM, Jenkins CM, Zhuang S, Daman AW, Chiu EY, Bates BM, Greenberg PD. A Fas-4-1BB fusion protein converts a death to a pro-survival signal and enhances T cell therapy. J Exp Med. 2020 Dec 7;217(12). doi: 10.1084/jem.20191166. PubMed PMID: 32860705; PubMed Central PMCID: PMC7953733.

select

Morse CB, Voillet V, Bates BM, Chiu EY, Garcia NM, Gottardo R, Greenberg PD, Anderson KG. Development of a clinically relevant ovarian cancer model incorporating surgical cytoreduction to evaluate treatment of micro-metastatic disease. Gynecol Oncol. 2021 Feb;160(2):427-437. doi: 10.1016/j.ygyno.2020.11.009. Epub 2020 Nov 20. PubMed PMID: 33229044; PubMed Central PMCID: PMC8547140.

select

Su Y, Chen D, Yuan D, Lausted C, Choi J, Dai CL, Voillet V, Duvvuri VR, Scherler K, Troisch P, Baloni P, Qin G, Smith B, Kornilov SA, Rostomily C, Xu A, Li J, Dong S, Rothchild A, Zhou J, Murray K, Edmark R, Hong S, Heath JE, Earls J, Zhang R, Xie J, Li S, Roper R, Jones L, Zhou Y, Rowen L, Liu R, Mackay S, O'Mahony DS, Dale CR, Wallick JA, Algren HA, Zager MA, ISB-Swedish COVID19 Biobanking Unit, Wei W, Price ND, Huang S, Subramanian N, Wang K, Magis AT, Hadlock JJ, Hood L, Aderem A, Bluestone JA, Lanier LL, Greenberg PD, Gottardo R, Davis MM, Goldman JD, Heath JR. Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19. Cell. 2020 Dec 10;183(6):1479-1495.e20. doi: 10.1016/j.cell.2020.10.037. Epub 2020 Oct 28. PubMed PMID: 33171100; PubMed Central PMCID: PMC7598382.

select

Manzo T, Prentice BM, Anderson KG, Raman A, Schalck A, Codreanu GS, Nava Lauson CB, Tiberti S, Raimondi A, Jones MA, Reyzer M, Bates BM, Spraggins JM, Patterson NH, McLean JA, Rai K, Tacchetti C, Tucci S, Wargo JA, Rodighiero S, Clise-Dwyer K, Sherrod SD, Kim M, Navin NE, Caprioli RM, Greenberg PD, Draetta G, Nezi L. Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8+ T cells. J Exp Med. 2020 Aug 3;217(8). doi: 10.1084/jem.20191920. PubMed PMID: 32491160; PubMed Central PMCID: PMC7398173.

select

Anderson KG, Voillet V, Bates BM, Chiu EY, Burnett MG, Garcia NM, Oda SK, Morse CB, Stromnes IM, Drescher CW, Gottardo R, Greenberg PD. Engineered Adoptive T-cell Therapy Prolongs Survival in a Preclinical Model of Advanced-Stage Ovarian Cancer. Cancer Immunol Res. 2019 Sep;7(9):1412-1425. doi: 10.1158/2326-6066.CIR-19-0258. Epub 2019 Jul 23. PubMed PMID: 31337659; PubMed Central PMCID: PMC6726582.

select

Chapuis AG, Egan DN, Bar M, Schmitt TM, McAfee MS, Paulson KG, Voillet V, Gottardo R, Ragnarsson GB, Bleakley M, Yeung CC, Muhlhauser P, Nguyen HN, Kropp LA, Castelli L, Wagener F, Hunter D, Lindberg M, Cohen K, Seese A, McElrath MJ, Duerkopp N, Gooley TA, Greenberg PD. T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant. Nat Med. 2019 Jul;25(7):1064-1072. doi: 10.1038/s41591-019-0472-9. Epub 2019 Jun 24. PubMed PMID: 31235963; PubMed Central PMCID: PMC6982533.

select

Paulson KG, Voillet V, McAfee MS, Hunter DS, Wagener FD, Perdicchio M, Valente WJ, Koelle SJ, Church CD, Vandeven N, Thomas H, Colunga AG, Iyer JG, Yee C, Kulikauskas R, Koelle DM, Pierce RH, Bielas JH, Greenberg PD, Bhatia S, Gottardo R, Nghiem P, Chapuis AG. Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA. Nat Commun. 2018 Sep 24;9(1):3868. doi: 10.1038/s41467-018-06300-3. PubMed PMID: 30250229; PubMed Central PMCID: PMC6155241.

select

Harris DT, Hager MV, Smith SN, Cai Q, Stone JD, Kruger P, Lever M, Dushek O, Schmitt TM, Greenberg PD, Kranz DM. Comparison of T Cell Activities Mediated by Human TCRs and CARs That Use the Same Recognition Domains. J Immunol. 2018 Feb 1;200(3):1088-1100. doi: 10.4049/jimmunol.1700236. Epub 2017 Dec 29. PubMed PMID: 29288199; PubMed Central PMCID: PMC5780198.

select

Schmitt TM, Aggen DH, Ishida-Tsubota K, Ochsenreither S, Kranz DM, Greenberg PD. Generation of higher affinity T cell receptors by antigen-driven differentiation of progenitor T cells in vitro. Nat Biotechnol. 2017 Dec;35(12):1188-1195. doi: 10.1038/nbt.4004. Epub 2017 Nov 6. PubMed PMID: 29106410; PubMed Central PMCID: PMC5722674.

select

Stromnes IM, Hulbert A, Pierce RH, Greenberg PD, Hingorani SR. T-cell Localization, Activation, and Clonal Expansion in Human Pancreatic Ductal Adenocarcinoma. Cancer Immunol Res. 2017 Nov;5(11):978-991. doi: 10.1158/2326-6066.CIR-16-0322. Epub 2017 Oct 24. PubMed PMID: 29066497; PubMed Central PMCID: PMC5802342.